[ Price : $8.95]
FDA publishes the latest CDER guidance agenda showing plans for 85 new or revised guidances to be issued in 2026.[ Price : $8.95]
FDA approves Merck's Lipfendra (enlicitide) 20 mg tablets as an adjunct to diet and exercise to reduce low-density lipoprotein cho...[ Price : $8.95]
Kalshi launches a pilot program allowing traders to buy and sell contracts tied to the outcomes of late-stage clinical trials and ...[ Price : $8.95]
FDA releases the form FDA-483 with 13 observations from an April inspection at Chinas Zhejiang Hushai Pharmaceutical Co.[ Price : $8.95]
The American Society of Health System Pharmacists says there were 227 active drug shortages in the second quarter of 2026, trendin...[ Price : $8.95]
Rep. Diana DeGette (D-CO) wins FDA assurances that several policy announcements issued during former commissioner Marty Makary's t...[ Price : $8.95]
FDA warns Irvine, CA-based Nihon Kohden Digital Health Solutions that it is marketing an adulterated and misbranded unapproved med...[ Price : $8.95]
Witnesses at a House Energy and Commerce Health Subcommittee hearing urge lawmakers to modernize the nation's clinical trial syste...